Equipoise

From Glossary for Health Technology Lifecycle by EuroScan
Revision as of 15:54, 8 November 2023 by Editor iHTS (talk | contribs) (Created page with "''<small><sup>¹⁵Freedman B. Equipoise and the ethics of clinical research. N Eng J Med. 1987;317(3):141–145.</sup> <sup>16Rodrigues HC, van den Berg PP. Randomized controlled trials of maternal-fetal surgery: a challenge to clinical equipoise. Bioethics. 28(8): 405–413. ¹⁶Rodrigues HC, van den Berg PP. Randomized controlled trials of maternal-fetal surgery: a challenge to clinical equipoise. Bioethics. 28(8): 405–413.</sup></small>'' A state of genuine unce...")

(diff) ← Older revision | Approved revision (diff) | Latest revision (diff) | Newer revision → (diff)

¹⁵Freedman B. Equipoise and the ethics of clinical research. N Eng J Med. 1987;317(3):141–145. 16Rodrigues HC, van den Berg PP. Randomized controlled trials of maternal-fetal surgery: a challenge to clinical equipoise. Bioethics. 28(8): 405–413. ¹⁶Rodrigues HC, van den Berg PP. Randomized controlled trials of maternal-fetal surgery: a challenge to clinical equipoise. Bioethics. 28(8): 405–413.


A state of genuine uncertainty as to which of two or more alternative health technologies should constitute the standard of care, considering benefits and harms.

Note 1: Equipoise is widely viewed as necessary for a trial to be ethically justified, especially when participants are assigned to trial arms randomly. This view is underpinned by the idea that physician-researchers cannot waive their duty to act in the best interests of their patients.

Note 2: As specified by the definition, equipoise usually refers to the state of uncertainty inhabited by the scientific and medical community, but it can also refer to the state of uncertainty inhabited by the researchers conducting a trial or by patients and the public.

[1]